| |  Researchers from the Mount Sinai School of Medicine have identified a potential new target for the treatment of a particularly aggressive form of bladder cancer. MicroRNAs are small non-coding pieces of genetic material that are involved in the regulation of gene expression. | |
|
| |  A potential new target for treatment has been identified in an aggressive form of bladder cancer, Mount Sinai researchers report. | |
|
| |  Patients who are unlikely to benefit from a commonly used immunotherapy for bladder cancer could be identified by a simple blood test, according to researchers at Brighton and Sussex Medical School. | |
|
| |  To date, there have been more than 80,000 cases of bladder cancer in the US. The best way of boosting the prognosis of patients is through early intervention, which can be achieved through the identification of bladder cancer biomarkers. | |
|
| |  Histopathology provides a vast amount of valuable information about bladder cancer, such as the type, stage and grade of the cancer. This enables doctors to assess patient prognosis, best treatment options and possible specific therapies. | |
|
| |  Endoscopy (or endoscopic imaging) is the internal visualisation of an organ using a camera encapsulated within a long, flexible tube. Endoscopy of the bladder, more commonly referred to as cystoscopy, is the gold standard for detection and monitoring bladder cancer. | |
|
| |  Bladder cancer is initiated when the cells of the bladder lining begin to grow uncontrollably, forming a tumor. This tumor then continues to grow, entering the muscle and the blood stream, eventually metastasising to other organs in the body. | |
|
| |  There are many techniques which are used to diagnose and monitor bladder cancer, but the most common are highly invasive. These techniques cause anxiety for the patient and can impact how early the cancer can be detected. Since early diagnosis is key for boosting patient prognosis, several non-invasive techniques have been suggested as possible alternatives to these traditional methods. | |
|
| |  Bladder cancer develops most commonly in the urothelial lining of the bladder. According GLOBOCAN database 2012, it is the 9th most common type of cancer worldwide, with 430,000 newly diagnosed cases in 2012. | |
|
| |  Bladder cancer mostly develops in the urothelium that forms the inner lining of the urinary bladder. Other rare forms of this cancer include squamous cell carcinoma and adenocarcinoma. | |
|
| |  Muscle invasive bladder cancer (MIBC) is a type of transitional cell carcinoma that originates from the urothelium and gradually invades the detrusor muscle of the urinary bladder. | |
|
| |  Researchers have created patient-specific bladder cancer organoids that imitate many of the features of real tumors and may therefore be used to study how cancer evolves. | |
